Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Investigative Ophthalmology & Visual Science|March 31, 2016
Digoxin Inhibits Induction of Experimental Autoimmune Uveitis in Mice, but Causes Severe Retinal DegenerationSamuel J H Hinshaw, Osato Ogbeifun, Wambui S Wandu, et al.
Clinical & Experimental Ophthalmology|October 23, 2018
Two different initial treatment regimens of ranibizumab in myopic choroidal neovascularization: 12-month results from a randomized controlled studySongshan Li, Xiaoyan Ding, Limei Sun, et al.
Experimental and Therapeutic Medicine|August 10, 2021
Multimodal imaging and genetic analysis of adult-onset best vitelliform macular dystrophy in Chinese patientsYing Lin, Tao Li, Bingqian Liu, et al.
Retina (Philadelphia, Pa.)|December 22, 2018
MORPHOLOGICAL CHARACTERISTICS AND VISUAL ACUITY OF HIGHLY MYOPIC EYES WITH DIFFERENT SEVERITIES OF MYOPIC MACULOPATHYXiujuan Zhao, Xiaoyan Ding, Cancan Lyu, et al.
Frontiers in Immunology|February 11, 2021
Regulated Tristetraprolin Overexpression Dampens the Development and Pathogenesis of Experimental Autoimmune UveitisBiying Xu, Jihong Tang, Cancan Lyu, et al.
European Journal of Immunology|September 16, 2018
TMP778, a selective inhibitor of RORγt, suppresses experimental autoimmune uveitis development, but affects both Th17 and Th1 cell populationsCancan Lyu, So Jin Bing, Wambui S Wandu, et al.
Pageof 3